2017
DOI: 10.1016/j.clinbiochem.2017.06.013
|View full text |Cite
|
Sign up to set email alerts
|

The transferrin isoforms in chronic hepatitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 14 publications
0
6
0
Order By: Relevance
“…As expected, the total transferrin concentration was diminished in both forms of pancreatitis, with an apparent greater decrease in acute pancreatitis. Looking at our earlier works, we can only see a similarity to the profile of transferrin isoforms in chronic hepatitis [ 13 ]. At the same time, we find differences in the transferrin isoform profile in other liver diseases [ 9 ]; in rheumatic diseases, including rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and juvenile idiopathic arthritis [ 11 , 12 , 14 ]; and in pancreatic cancers [ 6 ].…”
Section: Discussionmentioning
confidence: 94%
See 2 more Smart Citations
“…As expected, the total transferrin concentration was diminished in both forms of pancreatitis, with an apparent greater decrease in acute pancreatitis. Looking at our earlier works, we can only see a similarity to the profile of transferrin isoforms in chronic hepatitis [ 13 ]. At the same time, we find differences in the transferrin isoform profile in other liver diseases [ 9 ]; in rheumatic diseases, including rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and juvenile idiopathic arthritis [ 11 , 12 , 14 ]; and in pancreatic cancers [ 6 ].…”
Section: Discussionmentioning
confidence: 94%
“…In this paper, we tried to determine the profile of transferrin isoforms in pancreatitis, in acute as well as in chronic forms of disease, in accordance with the knowledge on the changes of protein glycosylation in the course of inflammatory diseases. Because we previously assessed the profile of transferrin isoforms in many different diseases, including liver diseases, rheumatic diseases and pancreatic cancers, we have the opportunity to compare the changes in pancreatitis with the changes in the diseases mentioned above [ 6 , 10 , 11 , 13 ]. This situation created the possibility to show whether these changes are characteristic for pancreatitis or only organ-dependent inflammation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The relative concentration of tetra- and pentasialotransferrin did not change. In our previous studies, we showed that the shift in one isoform of transferrin causes the reverse shift in the other, e.g., the increased level of tetrasialotransferrin was accompanied by the decreased level of pentasialotransferrin in the course of chronic hepatitis [ 25 ], and in pancreatic cancer [ 26 ], or mixed effect in the form of a significant decrease in tri- and pentasialotransferrin and a significant increase in tetrasialotransferrin in patients with rheumatoid arthritis [ 27 ]. Opposite changes in transferrin isoforms aim to maintain a stable level of transferrin.…”
Section: Discussionmentioning
confidence: 99%
“…Transferrin is the iron-binding serum glycoprotein which is produced in hepatocytes and contains two N-linked glycosylation sites (4,5). An abnormal glycosylation is also a known phenomenon in liver disease patients; it has been described in alcoholic liver disease (decreased enzyme activities of mannosyltransferase and galactosyltransferase, lowered intracellular dolichol concentration, desialylation of serum Tf, α1-antitrypsin and ceruloplasmin; hyperfucosylation of haptoglobin and serum Tf), galactosemia and fructosemia (the pattern resembling CDG type I), chronic hepatitis B and C, non-alcoholic steatohepatitis, and bile-related liver diseases (6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21). Despite of IEF, there are also some other methods, like HPLC or MALDI-TOF but they are not available in Poland.…”
Section: Introductionmentioning
confidence: 99%